Investment
Features
FeesSafety
Academy
More
Pluang+

Compare MPLX LP (MPLX) vs Zimmer Biomet Holdings Inc (ZBH) Price & Performance

MPLX LPTrade
Zimmer Biomet Holdings IncTrade

Price performance (Past 24H)

Key statistics

MPLX LP vs Zimmer Biomet Holdings Inc — how do they compare? MPLX LP trades at $56.64 (market cap $57.97B), while Zimmer Biomet Holdings Inc trades at $90.03 (market cap $17.36B). The key difference: MPLX LP is far larger — about 3.3× Zimmer Biomet Holdings Inc's market cap, and MPLX LP pays the higher dividend (7.54%). Which is the better fit depends on your goals.

MPLXZBH
Market Cap
$57.97B$17.36B
Sector
TechnologyHealth
52-Week High
$59.17$107.71
52-Week Low
$47.80$79.58
Enterprise Value
$82.60B$24.40B
Dividend Yield
7.54%1.07%

Aura AI Summary

Signals from Pluang's Aura AI — not financial advice

MPLX LP

No Aura AI signal available yet.

Zimmer Biomet Holdings Inc

Zimmer Biomet (ZBH) trades at $88.92, down 2.41% on the day, with a bearish technical signal but strong fundamentals including a 70.03% gross margin and three consecutive quarterly EPS beats. Revenue grew to $8.23B in 2025, though net income margin compressed to 8.56%. The company announced a $1 billion share repurchase increase and expansion in India, while maintaining a dividend.

The stock offers a 10% upside to the $97.67 consensus price target, supported by value metrics and operational strength, but faces risks from rising debt levels and competitive pressures. Analyst sentiment is mixed with 40% buy ratings, suggesting cautious optimism amid near-term technical weakness.

Returns comparison

Trailing returns across standard periods

Top news

Latest headlines on both assets

About MPLX LP

MPLX LP is a Master Limited Partnership (MLP) formed by Marathon Petroleum Corporation (MPC). It is a diversified, growth-oriented company primarily engaged in the gathering, processing, and transportation of natural gas and natural gas liquids (NGLs), as well as the transportation, storage, and distribution of crude oil and refined petroleum products. MPLX owns and operates a network of midstream energy infrastructure assets, providing essential services to the energy industry across the United States.

Read more on MPLX

About Zimmer Biomet Holdings Inc

Zimmer Biomet designs, manufactures, and markets orthopedic reconstructive implants, as well as supplies and surgical equipment for orthopedic surgery. With the acquisitions of Centerpulse in 2003 and Biomet in 2015, Zimmer holds the leading share of the reconstructive market in the United States, Europe, and Japan. Roughly 70% of total revenue is derived from sales of large joints, another quarter comes from extremities, trauma, and related surgical products.

Read more on ZBH